Rodrigo Daza-Arnedo
4PUBLICATIONS
25CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Mar 18, 2026
Renal Outcomes of GLP-1 Receptor Agonists and Tirzepatide Across CKD Stages and Metabolic Phenotypes (Type 2 Diabetes and/or Overweight/Obesity): A Scoping Review.Jorge Rico-Fontalvo, Rodrigo Daza-Arnedo, Alicia Elbert
|Mar 24, 2025
Combining GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes Mellitus: A Scoping Review and Expert Insights for Clinical Practice Utilizing the Nominal Group Technique.Carlos A Yepes-Cortés, Isabel C Cardenas-Moreno, Rodrigo Daza-Arnedo
|Nov 08, 2024
Kidney effects of Glucagon-Like Peptide 1 (GLP1): from molecular foundations to a pharmacophysiological perspective.Jorge Rico-Fontalvo, Maricely Reina, María José Soler
|May 22, 2024
The Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA), Associated with Renal Compromise and Cutaneous Calcinosis: A Case Report and Literature Review.Cristian Betancur Henao, Juan Guillermo Rifaldo, Rafael Vicente-Pérez
Pageof 1
Frequent Collaborators
3 joint publications
Jorge Rico-Fontalvo
2 joint publications
Carlos E Builes-Montaño
2 joint publications
Thyago Proença de Moraes
1 joint publications
Cristian Betancur Henao
1 joint publications
Juan Guillermo Rifaldo
1 joint publications
Rafael Vicente-Pérez
1 joint publications
Maria Cristina Martinez-Avila
1 joint publications
Maricely Reina
1 joint publications
Vicente Sánchez-Polo
1 joint publications
Mario Unigarro-Palacios
